Gene manipulation to enhance MIBG-targeted radionuclide therapy

Mairs, R. , Fullerton, N., Cosimo, E. and Boyd, M. (2005) Gene manipulation to enhance MIBG-targeted radionuclide therapy. Nuclear Medicine and Biology, 32(7), pp. 749-753. (doi: 10.1016/j.nucmedbio.2005.03.011)

Full text not currently available from Enlighten.

Abstract

The goal of targeted radionuclide therapy is the deposition in malignant cells of sterilizing doses of radiation without damaging normal tissue. The radiopharmaccutical [I-131] meta-iodobenzylguanidine ([I-131]MIBG) is an effective single agent for the treatment of neuroblastoma. However, uptake of the drug in malignant sites is insufficient to cure disease. A growing body of experimental evidence indicates exciting possibilities for the integration of gene transfer with [I-131]MIBG-targeted radiotherapy.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Mairs, Professor Robert and Boyd, Dr Marie
Authors: Mairs, R., Fullerton, N., Cosimo, E., and Boyd, M.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Nuclear Medicine and Biology
ISSN:0969-8051

University Staff: Request a correction | Enlighten Editors: Update this record